Antiretroviral therapy, sexually transmitted infections, and adverse pregnancy outcomes in South Africa
- UPSpace Home
- →
- Workspace (UPSpace)
- →
- Arthur (Articles)
- →
- View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.
| dc.contributor.author | Peters, Remco P.H.
|
|
| dc.contributor.author | Davey, Dvora L. Joseph
|
|
| dc.contributor.author | Bekker, Linda-Gail
|
|
| dc.contributor.author | Myer, Landon
|
|
| dc.contributor.author | Medina-Marino, Andrew
|
|
| dc.contributor.author | Klausner, Jeffrey D.
|
|
| dc.date.accessioned | 2022-07-22T10:44:13Z | |
| dc.date.available | 2022-07-22T10:44:13Z | |
| dc.date.issued | 2021-08 | |
| dc.description.abstract | We read with interest the article by Theron et al. on their post hoc analysis of the Promoting Maternal and Infant Survival Everywhere (PROMISE) 1077BF/1077FF trials. They found an increased incidence of low birth-weight (LBW) infants (<2500 g) and adverse pregnancy outcomes in women who conceived while on antiretroviral therapy (ART) compared with those who restarted ART after pregnancy was diagnosed. Their study adds an important data point to the limited, and sometimes contradictory, evidence regarding safety of ART in pregnancy and its relationship with adverse pregnancy outcomes. | en_US |
| dc.description.department | Medical Microbiology | en_US |
| dc.description.librarian | am2022 | en_US |
| dc.description.sponsorship | The Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health (NIH); the President’s Emergency Plan for AIDS Relief through the US Agency for International Development; the NIH and Fogarty International Center; the National Institute of Mental Health; the National Institute for Allergy and Infectious Diseases. | en_US |
| dc.description.uri | https://academic.oup.com/cid | en_US |
| dc.identifier.citation | Peters, R.P.H., Davey, D.L.J., Bekker, L.-G. et al. 2021, 'Antiretroviral Therapy, Sexually Transmitted Infections, and Adverse Pregnancy Outcomes in South Africa', Clinical Infectious Diseases, vol. 73, no. 3, pp. e851-e852. | en_US |
| dc.identifier.issn | 1058-4838 (print) | |
| dc.identifier.issn | 1537-6591 (online) | |
| dc.identifier.other | 10.1093/cid/ciaa1669 | |
| dc.identifier.uri | https://repository.up.ac.za/handle/2263/86403 | |
| dc.language.iso | en | en_US |
| dc.publisher | Oxford University Press | en_US |
| dc.rights | © The Author(s) 2020. | en_US |
| dc.subject | Pregnancy | en_US |
| dc.subject | Infants | en_US |
| dc.subject | Antiretroviral therapy (ART) | en_US |
| dc.subject | Low birth weight (LBW) | en_US |
| dc.title | Antiretroviral therapy, sexually transmitted infections, and adverse pregnancy outcomes in South Africa | en_US |
| dc.type | Article | en_US |
